BioCentury
ARTICLE | Clinical News

PrEP-001: Ph IIa PrEP-CS-002 data

February 17, 2017 7:54 PM UTC

The double-blind Phase IIa PrEP-CS-002 trial in 39 evaluable patients with mild to moderate controlled asthma challenged with HRV-16 showed that PrEP-001 missed the primary endpoint of improving patie...